Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Samarium Diiodide Catalysis for Novel Bioiosteres

Project description

Photoactivation for enhanced Sml2 catalytic efficiency

Bioisosteric replacement of aromatic pharmacophores is a strategy in drug development to reduce the formation of toxic metabolites. Substituting aromatic cores with rigid, carbon-rich scaffolds can improve both metabolic stability and potency. However, many analogues remain unexplored due to the lack of efficient synthetic methods. Recent work has made significant progress in this area using SmI2 in radical relay catalysis to enable the synthesis of bioisosteric scaffolds. With support from the Marie Skłodowska-Curie Actions programme, the Sam-4-Bio project will build on this progress by integrating a novel approach with recent discoveries on enhancing SmI2 catalytic efficiency. The project aims to develop a versatile platform for generating bioisosteres of ortho-arenes, such as 1,2-BCHeps.

Objective

The concept of bioisosteric replacement of arene pharmacophores in drug candidates has garnered increasing attention as a powerful tool to circumvent the production of toxic metabolites through detrimental metabolic modifications of the arene backbone. Replacement of the arene core in drug candidates with rigid, C(sp3)-rich bioisosteric scaffold improves their metabolic stability, potency, lipophilicity, and solubility. Crucially, cage-like structures with defined exit vectors renders them bioisosteres with superior ability to dock in the chiral binding pocket of the target receptor. Therefore, the demand for C(sp3)-rich bioisosteric replacements is skyrocketing and recent endeavors have provided a variety of decorated saturated systems mimicking substituted arenes. While initial studies were mostly directed towards bioisosteres of mono- and para-substituted arenes, recent efforts have focussed more on bioisosteres for ortho- and meta-substituted aromatic rings. Despite the significant development of synthetic strategies for preparing already proven bioisosteres, the lack of synthetic methods to access many unexplored analogues, such as bicyclo[2.2.1]heptanes (BCHeps), renders their potential undetermined to date. Consequently, developing general, catalytic, sustainable methods for rapidly accessing 1,2-BCHeps is an urgent necessity. Recent breakthroughs from the Procter group have set a new benchmark by applying radical relay catalysis using SmI2 for accessing bioisosteric scaffolds. Sam-4-Bio will integrate this novel concept with the group’s recent finding of enhancing catalytic efficiency of SmI2 by photoactivation, to develop a catalytic platform for accessing unexplored bioisosteres of ortho-arenes like 1,2-BCHeps. Challenging insertion of alkene into the bridgehead bond of strained housane ketones under SmI2-catalysis will deliver key intermediates for downstream manipulation en route to new saturated analogues of validated drugs with superior bioactivity.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

THE UNIVERSITY OF MANCHESTER
Net EU contribution
€ 276 187,92
Address
OXFORD ROAD
M13 9PL Manchester
United Kingdom
Region
North West (England) Greater Manchester Manchester
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data